Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10941025 | Immunobiology | 2013 | 5 Pages |
Abstract
Homozygosity for a 32Â bp deletion in CCR5 (CCR5-Î32/Î32) is associated with strong resistance against HIV-1 infection. Several HLA types have been associated to improved viral control and/or delayed progression to AIDS. We report a unique HIV-1 infected individual homozygous for CCR5-Î32/Î32 and carrier of HLA-A*2402 and HLA-B*5701. In comparison with earlier data and although a replication competent virus has been isolated, the patient presents better immune status, response to treatment and disease evolution, which may be related to the control exerted by HLA class I restricted T cell immunity. Importantly, the accumulation of protective factors does not warrant a complete protection to HIV infection and the subsequent life-long treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Ester Ballana, Eva Riveira-Munoz, Christian Pou, Vanessa Bach, Mariona Parera, Marc Noguera, José R. Santos, Roger Badia, Maria Casadellà , Bonaventura Clotet, Roger Paredes, Miguel Angel MartÃnez, Christian Brander, José A. Esté,